AU2021901241A0 - Thermally stable vaccine formulations - Google Patents

Thermally stable vaccine formulations

Info

Publication number
AU2021901241A0
AU2021901241A0 AU2021901241A AU2021901241A AU2021901241A0 AU 2021901241 A0 AU2021901241 A0 AU 2021901241A0 AU 2021901241 A AU2021901241 A AU 2021901241A AU 2021901241 A AU2021901241 A AU 2021901241A AU 2021901241 A0 AU2021901241 A0 AU 2021901241A0
Authority
AU
Australia
Prior art keywords
thermally stable
vaccine formulations
stable vaccine
formulations
thermally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2021901241A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commonwealth Scientific and Industrial Research Organization CSIRO
Original Assignee
Commonwealth Scientific and Industrial Research Organization CSIRO
Filing date
Publication date
Application filed by Commonwealth Scientific and Industrial Research Organization CSIRO filed Critical Commonwealth Scientific and Industrial Research Organization CSIRO
Publication of AU2021901241A0 publication Critical patent/AU2021901241A0/en
Priority to AU2022265735A priority Critical patent/AU2022265735A1/en
Priority to EP22794101.0A priority patent/EP4329814A1/en
Priority to PCT/AU2022/050390 priority patent/WO2022226594A1/en
Pending legal-status Critical Current

Links

AU2021901241A 2021-04-27 2021-04-27 Thermally stable vaccine formulations Pending AU2021901241A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU2022265735A AU2022265735A1 (en) 2021-04-27 2022-04-27 Thermally stable vaccine formulations utilising metal organic framework (mof) shells
EP22794101.0A EP4329814A1 (en) 2021-04-27 2022-04-27 Thermally stable vaccine formulations utilising metal organic framework (mof) shells
PCT/AU2022/050390 WO2022226594A1 (en) 2021-04-27 2022-04-27 Thermally stable vaccine formulations utilising metal organic framework (mof) shells

Publications (1)

Publication Number Publication Date
AU2021901241A0 true AU2021901241A0 (en) 2021-05-13

Family

ID=

Similar Documents

Publication Publication Date Title
EP3585803A4 (en) Pneumococcal conjugate vaccine formulations
GB202212336D0 (en) Coronavirus vaccine formulations
EP3600396A4 (en) Nucleic acid vaccine composition comprising a lipid formulation, and method of increasing the potency of nucleic acid vaccines
EP3773721A4 (en) Stable anti-cd79b immunoconjugate formulations
EP3946320A4 (en) Hsp90-binding conjugates and formulations thereof
EP3603619A4 (en) Vaccine adjuvant formulation
EP4072553A4 (en) Cariprazine release formulations
WO2010053610A3 (en) Stable anthrax vaccine formulations
EP3827842A4 (en) Composition containing influenza vaccine
EP3746078A4 (en) Oral formulations and uses thereof
EP4007590A4 (en) Formulations including dihydrohonokiol
EP3908316A4 (en) Tlr4-tlr7 ligand formulations as vaccine adjuvants
EP4065166A4 (en) Excipient compounds for biopolymer formulations
EP3903810A4 (en) Preparation including vaccine adjuvant
EP3886820B8 (en) Capsule formulations
AU2021901241A0 (en) Thermally stable vaccine formulations
EP4048276A4 (en) Solid pharmaceutical formulations comprising ticagrelor
AU2021901467A0 (en) Thermally stable formulations
EP3923981A4 (en) Vaccine adjuvants and formulations
EP4013441A4 (en) Larazotide formulations
EP3585397A4 (en) Solid oral formulations of amphotericin b
EP3801532A4 (en) Formulations of raltegravir
AU2020903704A0 (en) Immunogenic formulations
AU2022399829A1 (en) Coronavirus vaccine formulations
EP3389786A4 (en) Thermally stable rotavirus vaccine formulations and methods of use thereof